Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
06 06 2023
Historique:
medline: 8 6 2023
pubmed: 21 5 2023
entrez: 21 5 2023
Statut: ppublish

Résumé

Airway mucus plugs are common in patients with chronic obstructive pulmonary disease (COPD); however, the association of airway mucus plugging and mortality in patients with COPD is unknown. To determine whether airway mucus plugs identified on chest computed tomography (CT) were associated with increased all-cause mortality. Observational retrospective analysis of prospectively collected data of patients with a diagnosis of COPD in the Genetic Epidemiology of COPD cohort. Participants were non-Hispanic Black or White individuals, aged 45 to 80 years, who smoked at least 10 pack-years. Participants were enrolled at 21 centers across the US between November 2007 and April 2011 and were followed up through August 31, 2022. Mucus plugs that completely occluded airways on chest CT scans, identified in medium- to large-sized airways (ie, approximately 2- to 10-mm lumen diameter) and categorized as affecting 0, 1 to 2, or 3 or more lung segments. The primary outcome was all-cause mortality, assessed with proportional hazard regression analysis. Models were adjusted for age, sex, race and ethnicity, body mass index, pack-years smoked, current smoking status, forced expiratory volume in the first second of expiration, and CT measures of emphysema and airway disease. Among the 4483 participants with COPD, 4363 were included in the primary analysis (median age, 63 years [IQR, 57-70 years]; 44% were women). A total of 2585 (59.3%), 953 (21.8%), and 825 (18.9%) participants had mucus plugs in 0, 1 to 2, and 3 or more lung segments, respectively. During a median 9.5-year follow-up, 1769 participants (40.6%) died. The mortality rates were 34.0% (95% CI, 32.2%-35.8%), 46.7% (95% CI, 43.5%-49.9%), and 54.1% (95% CI, 50.7%-57.4%) in participants who had mucus plugs in 0, 1 to 2, and 3 or more lung segments, respectively. The presence of mucus plugs in 1 to 2 vs 0 and 3 or more vs 0 lung segments was associated with an adjusted hazard ratio of death of 1.15 (95% CI, 1.02-1.29) and 1.24 (95% CI, 1.10-1.41), respectively. In participants with COPD, the presence of mucus plugs that obstructed medium- to large-sized airways was associated with higher all-cause mortality compared with patients without mucus plugging on chest CT scans.

Identifiants

pubmed: 37210745
pii: 2805343
doi: 10.1001/jama.2023.2065
pmc: PMC10201404
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1832-1839

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL164824
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL089856
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133137
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL089897
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL149861
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Alejandro A Diaz (AA)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

José L Orejas (JL)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Scott Grumley (S)

Department of Radiology, University of Alabama at Birmingham.

Hrudaya P Nath (HP)

Department of Radiology, University of Alabama at Birmingham.

Wei Wang (W)

Harvard Medical School, Boston, Massachusetts.
Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, Massachusetts.

Wojciech R Dolliver (WR)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Andrew Yen (A)

Department of Radiology, University of California, San Diego.

Seth J Kligerman (SJ)

Department of Radiology, University of California, San Diego.
now with Department of Radiology, National Jewish Health, Denver, Colorado.

Kathleen Jacobs (K)

Department of Radiology, University of California, San Diego.

Padma P Manapragada (PP)

Department of Radiology, University of Alabama at Birmingham.

Mostafa Abozeed (M)

Department of Radiology, University of Alabama at Birmingham.

Muhammad Usman Aziz (MU)

Department of Radiology, University of Alabama at Birmingham.

Mohd Zahid (M)

Department of Radiology, University of Alabama at Birmingham.

Asmaa N Ahmed (AN)

Department of Radiology, University of Alabama at Birmingham.

Nina L Terry (NL)

Department of Radiology, University of Alabama at Birmingham.

Ruben San José Estépar (R)

Harvard Medical School, Boston, Massachusetts.
Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.

Victor Kim (V)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.

Barry J Make (BJ)

Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health, Denver, Colorado.

MeiLan K Han (MK)

Division of Pulmonary and Critical Care at the University of Michigan, Ann Arbor.

Sushilkumar Sonavane (S)

Department of Radiology, Mayo Clinic, Jacksonville, Florida.

George R Washko (GR)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Michael Cho (M)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Raúl San José Estépar (R)

Harvard Medical School, Boston, Massachusetts.
Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH